Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
G1 Therapeutics, Inc. (GTHX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/21/2021 |
8-K
| Quarterly results |
| 09/30/2020 |
8-K
| Quarterly results |
| 06/13/2019 |
8-K
| Appointed a new director|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : June 12, 2019 G1 THERAPEUTICS, INC. Delaware 001-38096 26-3648180 79 T.W. Alexander Drive 4501 Research Commons, Suite 100 Research Triangle Park, NC 27709 Registrant's telephone number, including area code: 213-9835 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exc...",
"Amended and Restated Non-Employee Director Compensation Policy",
"Employment Agreement, by and between the Registrant and Rajesh K. Malik, M.D., as amended; First Amendment effective May 5, 2017, filed as to the Registrant's Second Amendment to the Registration Statement on Form S-1 filed on May 8, 2017 (File No. 333-217285) incorporated herein by reference; Second Amendment and filed herewith",
"Employment Agreement, by and between the Registrant and Terry Murdock, as amended; filed as to the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 filed on November 8, 2017 (File No. 001-38096) incorporated herein by reference; First Amendment and filed herewith",
"G1 Therapeutics Announces Updates to Board of Directors" |
|
|
|